Published 9 November 2009, doi:10.1136/bmj.b4617
Cite this as: BMJ 2009;339:b4617

News

GMC clears research dean of dishonesty

Clare Dyer

1 BMJ

The first 150 words of the full text of this article appear below.

The former research dean of Sheffield University’s medical school has been cleared by the General Medical Council of dishonesty in allowing the publication of a false statement saying that he had seen all the data in a research study of which he was the lead author.

The GMC held that although Richard Eastell might have acted negligently, he was not dishonest, he was not guilty of misconduct, and his fitness to practise was not impaired.

Professor Eastell, who heads the bone research unit at the university, was in charge of studies into Procter & Gamble’s osteoarthritis drug risedronate (Actonel). The university conducted measurements on blood and urine samples that had been taken during clinical trials in the 1990s for a study comparing the bone density measurements of women who had and had not taken the drug.

The measurements were sent to Procter & Gamble, which performed analyses, but the company . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

An evolving understanding?
A Clark
bmj.com, 11 Nov 2009 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ